Engineering Proteins via Peptide Backbone Mutagenesis: The Effects of Thioamide Linkages on the Folding and Stability of Short Peptides by Demick, Kristen Ann
Persistent link: http://hdl.handle.net/2345/724
This work is posted on eScholarship@BC,
Boston College University Libraries.
Boston College Electronic Thesis or Dissertation, 2009
Copyright is held by the author, with all rights reserved, unless otherwise noted.
Engineering Proteins via Peptide
Backbone Mutagenesis: The Eﬀects of
Thioamide Linkages on the Folding and
Stability of Short Peptides
Author: Kristen Ann Demick
 
 
 
Boston College 
 
 
The Graduate School of Arts and Sciences 
 
 
Department of Chemistry 
 
 
 
 
 
ENGINEERING PROTEINS VIA PEPTIDE BACKBONE MUTAGENESIS: THE EFFECTS  
 
OF THIOAMIDE LINKAGES ON THE FOLDING AND STABILITY OF SHORT PEPTIDES 
 
 
 
 
 
a thesis 
 
by 
 
KRISTEN ANN DEMICK 
 
 
 
submitted in partial fulfillment of the requirements  
 
for the degree of   
 
Master of Science  
 
 
 
August 2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 copyright by KRISTEN ANN DEMICK 
 
2009 
Engineering Proteins via Peptide Backbone Mutagenesis: The 
Effects of Thioamide Linkages on the Folding and Stability of 
Short Peptides 
 
 
By: Kristen A. Demick 
 
Advisor: Jianmin Gao 
 
 
Abstract 
 
The development of proteins/peptides as therapeutic agents has emerged as a 
promising area for drug design. Due to increased antibiotic resistance, search for novel 
antibiotics has become a primary area of interest within the pharmaceutical industry. 
Antimicrobial peptides have been a significantly desirable model due to their innate 
cytolytic effects and favorable interaction with the membranes of bacterial cells within 
the host. Thioxylated analogues of biologically active peptides have shown increased 
enzymatic stability and increased selectivity and potency. Thioamide linkages have thus 
been installed in a variety of short peptides, replacing the backbone amide linkage, in 
order to study the effects on peptide conformation and stability. Several bioanalytical 
tools were used in the analysis including circular dichroism spectroscopy, NMR, size-
exclusion high performance liquid chromatography, and fluorescence. The mutation was 
well-accommodated within several systems, including Trpzip 4 and gramicidin A, and 
proved to have comparable, and in several cases, enhanced stability in comparison to the 
wild-type peptides.  
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1.1 Proteins/Peptides as Therapeutic Agents 
 
1.1.1 Overview 
As one of the most studied fields in modern chemical biology, the possibilities in 
using proteins as therapeutics seem endless. Their advantages must be exploited to their 
highest capacity. As biological entities, proteins are usually highly specific, which is a 
very desirable feature as a therapeutic agent. There are currently more than 130 proteins 
or peptides approved for clinical use by the FDA, and many more follow closely in 
development.1  
There are a variety of uses for protein therapeutics. First, there are a wide range of 
vaccines; for example, the hepatitis B vaccine. This was created by producing 
recombinant hepatitis B surface antigen (HBsAg) protein. Significant immunity to the 
hepatitis B virus results when a patient is treated with this protein. There are also a group 
of enzymes and regulatory proteins that serve as therapeutics. These are introduced into 
the body in the event of a protein deficiency or abnormal protein production. One 
example is providing lactase to patients lacking that gastrointestinal enzyme or replacing 
vital blood-clotting factors (factor VIII and IX) in haemophiliacs. A third group of 
therapeutics uses antigen recognition sites of immunoglobulin (Ig) molecules or the 
receptor-binding domains of native protein ligands to direct the immune system to 
destroy particularly targeted cells. Several of these proteins have been approved for the 
treatment of inflammatory diseases.1  
Diabetes, a common metabolism disorder, is a condition characterized by high 
blood glucose levels (hyperglycemia) brought on by defects in insulin secretion or insulin 
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action in the body. Insulin, a peptide hormone produced in the pancreas, is responsible 
for many metabolic functions and causes cells in the liver, muscle, and fat tissue to take 
up glucose from the blood. The body then stores the glucose as glycogen, a usable energy 
source. Insulin delivery can thus be a simple treatment to diabetes. Insulin is stored in the 
body as a hexamer, however, the active form is monomeric (Figure 1.1).2  
 
 
Figure 1.1: The structure of insulin. Space-filling model of the insulin monomer, 
believed to be biologically active (left). Carbon-green, hydrogen-white, oxygen-red, and 
nitrogen-blue. Right: insulin hexamer; A monomer unit is highlighted with the A chain in 
blue and the B chain in cyan. Yellow denotes disulfide bonds, and magenta spheres are 
zinc ions. Figure adapted from Reference 2. 
 
Some of the most prominent diseases in the present culture seem to be increasing 
in fatality rates. Peptide drug design has been making dramatic strides to solve these 
problems. For example, Enfuvirtide, commonly known as Fuzeon, is a chemically 
  
4
 
synthesized peptide serving as a fusion inhibitor of the HIV-1 virus from host T-cells. 
This moderately new drug, approved by the FDA in March of 2003, is a linear 36-amino 
acid peptide composed of naturally occuring L-amino acid residues: CH3CO-Tyr-Thr-
Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-
Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2. Fuzeon disrupts the 
final stage of fusion of the HIV-1 virus with the target cell, preventing uninfected cells 
from becoming infected. It binds to the host CD4+ cell receptor via a viral 
transmembrane protein GP41 preventing the conformational change necessary for the 
fusion of the viral membrane to the host cell membrane. Fusion (or entry) inhibitors are a 
new class of antiretroviral drugs,2 but are just one example of peptides serving as 
therapeutic agents.  
The promising development of these protein and peptide drugs leads to all the 
possible types of proteins that could be used as therapeutic agents. It is necessary, though, 
to better understand the structural requirements and metabolic stability, as well as 
mechanistic action in the host, in order to best advance the field.  
 
1.1.2 Antimicrobial Peptides  
One of the most promising areas for peptides as therapeutics are antimicrobial 
peptides. Antimicrobial peptides (AMPs) have been isolated from a variety of species, 
including bacteria, fungi, plant and animal life. In fact, most living organisms rely on 
AMPs as a crucial component of their natural defense system. They are responsible for 
the direct killing and immunomodulatory effects in host defense against pathogenic 
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organisms. AMPs exhibit activity against Gram-positive and –negative bacteria, yeasts, 
and fungi, as well as possessing antiviral and anticancer properties.3  
AMPs, also referred to as host-defense peptides, have a great diversity in their 
primary structure, however, the vast majority are relatively short and characterized by a 
predominance of cationic and hydrophobic amino acids. They differ in both secondary 
and tertiary structures, but are typically amphipathic in nature, containing both a 
hydrophilic and hydrophobic surface. This feature plays an important role in their 
antimicrobial mechanisms.4 The hydrophobicity allows for enhanced interaction with 
lipid bilayers, whereas its hydrophilic surface allows for favorable interactions with the 
surrounding aqueous environment.  
There are several classes of antimicrobial peptides. The most common are the 
linear cationic α-helical peptides, containing less than 40 amino acids. This class lacks 
cysteine residues and sometimes has a hinge or “kink” region in the middle of the 
peptide. Although in aqueous solutions these peptides are disordered, they convert to an 
α-helix in the presence of sodium dodecylsulphate micelles and phospholipid vesicles. 
The extent of α-helicity directly correlates to the antibacterial activity. Examples of 
peptides in this class are cecropins from insects and nematodes and LL36 from humans.5 
Other classes of AMPs have secondary structures such as β-sheet structures, 
however, these AMPs are generally less active than the well-defined α-helical peptides. 
There exist anionic and cationic peptides containing multiple cysteine residues that allow 
disulfide bond formation, inducing stable β-sheet character. These peptides form a 
diverse family of defensins. An example of a β-defensin (3 disulfide bonds) is HBD1 in 
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humans. There are also α-defensins comprised of four intramolecular disulfide bonds, for 
instance HNP-1 and -2 in humans.5  
Since the activity of AMPs is governed by factors such as conformation and 
structure, charge, size, and hydrophobicity, these factors must all be considered in drug 
development. Chemical synthesis of these peptides or analog peptidomimetics that will 
treat bacterial infections is desirable3 and could make a large impact on modern medicine. 
Because antibacterial resistance has increased dramatically, the demand for new 
antibiotics is very high, and because of the structural diversity and biological 
compatibility of peptides, they serve as a great target for a new class of drugs.  Though 
there exists a broad range of natural AMPs isolated in humans, they are still 
mechanistically puzzling.  
 
1.1.3 Peptide-Membrane Interactions 
Disruption of bacterial membranes is believed to be the mechanism of the 
antimicrobial action of AMPs. Mechanistic studies within model systems are thus 
necessary to see how these peptides are actually accomplishing membrane penetration. 
Membranes differ significantly with respect to their composition of lipids. This directly 
reflects the functional specialization of each particular membrane. In general, however, 
membranes contain proteins serving as transporters or enzymes covalently linked either 
directly to the lipids or to complex arrays of carbohydrates. Because the phospholipid 
bilayer is impermeable to polar compounds and charged solutes, often other factors are 
necessary for protein insertion. Nonpolar compounds, however, are most easily 
incorporated into membranes due to the thermodynamic driving force, hydrophobicity. 
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Fatty acyl groups of lipid tails accommodate the hydrophobic regions of amino acids, 
providing a close association with the membrane. This anchor cannot be perturbed 
without harsh denaturation conditions or other means that would interfere with the 
hydrophobics of the system. These proteins are referred to as integral membrane proteins. 
They differ from peripheral membrane proteins whose association with a membrane is 
governed by electrostatics and hydrogen bonding (and limited hydrophobic interactions) 
and can be released by a simple change of pH or ionic strength. Integral membrane 
proteins make up approximately 30% of all proteins, true for many species. 6 
Extensive research is being done within a variety of model systems in order to 
provide insight into other similar systems as to how these proteins interact with cell 
membranes. Cytolytic effects are believed to be a result of the peptide’s interaction with 
membranes. Furthermore, once the mechanism of attack is understood, peptide 
engineering will quickly advance and synthetic analogues can be prepared and used as 
therapeutic agents.7 
Several postulates have been made as to the mechanism of the antimicrobial-
peptide-induced killing of bacterial cells (Figure 1.2). First is the barrel-stave model. 
Here, the attached peptides aggregate on the surface of the membrane and insert into the 
bilayer so that the hydrophobic regions of the peptide align with the lipid core region, 
allowing for the hydrophilic regions to form the interior region of the pore. Next is the 
carpet model which is, again, initiated by the aggregation of the peptides on the 
membrane surface. The membrane is then disrupted because the peptides orient parallel 
to the surface of the lipid bilayer and form an extensive layer (“carpet”). Finally, in the 
toroidal model, the attached peptides aggregate and induce the lipid monolayers to bend 
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continuously through the pore so that the water core is lined by both the inserted peptides 
and the lipid head groups.5  
         
          A    B    C 
 
Figure 1.2: Models of antimicrobial-peptide-induced killing; insertion into bacterial 
membranes. (A) Barrel-stave model. (B) Carpet model. (C) Toroidal model. Note: 
hydrophilic regions shown in red, hydrophobic regions shown in blue. Figure adapted 
from Reference 5.  
 
 
1.2 Peptide Design: Backbone Mutagenesis 
 
1.2.1 Overview 
The chemical mutation of peptides can not only provide us with mechanistic 
information critical to the field of peptide-based drug design, but may also prove 
beneficial to the system by increasing the stability of the peptide and enhancing 
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enzymatic stability. There are several strategies of drug design, however, many factors 
are to be considered. As previously mentioned, the environments within which they will 
be analyzed and utilized are both important. One must also think about the protein 
conformation and folding tendencies before introducing mutations. 
The secondary and tertiary structures of proteins are the result of noncovalent 
interactions within the chain. Though they are quantitatively lower in energy than 
covalent bonds, these weak intramolecular forces provide substantial stabilizing effects 
on protein assemblies, in addition to governing their conformation specificity. Examples 
of noncovalent interactions include ionic interactions, hydrophobic interactions, van der 
Waals interactions, and of particular interest, hydrogen bonding.6  
Hydrogen bonding (H-bonding) is a prominent feature within folded proteins, as it 
dictates to a large degree the protein’s folding and stability. Within a native protein, the 
number of hydrogen bonds is maximized.6 Disturbing the hydrogen bonding network 
within a protein can be detrimental to its native form, or conversely can prove 
advantageous for the system.  
A backbone amide bond participates in a H-bonding interaction with the side 
chains and/or backbone of neighboring residues. Configured with the character of a trans 
double bond, the amide bond orients the H-bond donor (N-H) diametrically opposite 
from its partner, the H-bond acceptor (C=O). As a result of the π-conjugation of the 
amide bond, the flexibility of the peptide is limited, thus constricting its rotation and 
torsion angles, ϕ and ψ, however H-bonding potential is increased. The secondary 
structure of a peptide is controlled by these rotational boundaries, as well as steric 
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restrictions, and is stabilized by hydrogen bonds formed between main-chain peptide 
groups.8  
In a study involving ten well-refined proteins, it was observed that only 11% of 
C=O groups and 12% of N-H groups did not participate in any obvious hydrogen 
bonding contact. It was also found that main-chain to main-chain carbonyl to amide 
proton interactions were most predominate: 68% of the donors were N-H and 46% were 
accepted by C=O. This study proved that main-chain hydrogen bonding interactions 
weigh most heavily in contribution to secondary structure. Focus on side-chain 
interactions, then, is lessened and backbone modification studies become more crucial. 
Through peptide backbone engineering, the hydrogen bonding scaffold can be altered and 
used to probe the protein’s behavior.8 
 
1.2.2 Conversion of an Amide to an E-Olefin 
 One option for amide-bond mutagenesis is the conversion to an E-olefin (Figure 
1.3). This alkene moiety perturbs the H-bonding network by eliminating both a backbone 
H-bond acceptor and donor. Though the synthesis is challenging, its outcome could 
contribute substantially to peptide design. The isosteric mutation increases the 
hydrophobicity of the peptide, which could in turn increase membrane permeability and 
possibly potency. The outcome of such a transformation is governed by several factors 
that must be considered. Both entropic and enthalpic contributions play an important role 
in the peptide’s stability.9  
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Figure 1.3: Backbone modification of amide bond to E-olefin. 
 
Kelly and coworkers have initiated a project to determine the requirements for 
amyloidogenesis of the amyloid-beta protein by incorportating an E-olefin dipeptide 
isostere into a polypeptide backbone. This enables hydrogen bond perturbation, which 
could play a significant role in aggregation of the peptides. Using a stereoselective 
synthesis of the Phe-Phe E-olefin isostere, the group successfully prepared a peptide in 
adequate yield in order to examine the role of hydrogen bonding in protein structure.9  
 
 
Scheme 1.1: Synthesis of E-olefin isostere. Figure adapted from Reference 9.  
 
 Scheme 1.1 outlines the chemical synthesis of the desired dipeptide isostere. A 
Wittig reaction of the amino aldehyde, N-Boc-Phe-H, and n-BuLi, followed by a 
hydroboration-oxidation afforded the Phe-Gly isostere. Evan’s chiral oxazolidinone was 
then installed on the C-terminus of the dipeptide, condensing the acid. Finally, the 
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oxazolidinone enolate was subjected to excess benzyl bromide and diastereolectively 
alkylated. The structure of the Phe-Phe isostere was confirmed using X-ray 
crystallography (Figure 1.4).9  
 
 
Figure 1.4: The X-ray structure of the Phe-Phe E-olefin dipeptide isostere synthesized by 
the Kelly lab at Scripps. Adapted from Reference 9. 
 
 In order to examine the effect of removing both the H-bonding donor (amide 
proton) and H-bonding acceptor (carbonyl oxygen), the dipeptide was incorporated into 
the target peptide, Aβ-40 within the central, hydrophobic region (F19,20). Upon this 
removal, the peptide loses its primary region argued to dictate cross-β-sheet-based 
amyloid fibrils. Fluorescence experiments employing incubation of the peptide with 
thioflavin T (an environmentally sensitive fluor that binds and fluoresces when bound to 
spherical and cross-β-sheet aggregates of Aβ) showed that the mutant peptide was able to 
self-assemble. Circular dichroism was used to examine secondary structure, though 
results were somewhat inconclusive. Atomic force microscopy was then used, proving 
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that no fibril formation was observed within the mutant. They proved that the backbone 
modification indeed prevented the formation of spherical aggregates into fibrils.9 
 
Figure 1.5: Spatial disposition of amide and trans-olefin bonds. Distances in Å. Adapted 
from Reference 10.   
 
 Olefin installation in peptides is not a new approach. Research on these double 
bond isosteres has been carried out for several decades for several other purposes.10, 11 
Sammes and coworkers explored routes to peptide analogues using trans-carbon-carbon 
double bonds for use in Leu-enkephalin analogue synthesis. He proposed this to be a 
favorable isosteric replacement for it avoided use of D-amino acids so the spatial 
disposition of the natural peptide was not altered (Figure 1.5). Sammes hoped to use these 
analogues as peptidase inhibitors due to their high inhibitive efficacy.10 Later on, his team 
targeted two additional peptide analogues with new goals: (i) in order to provide stability 
  
14
 
and prevent enzymatic hydrolysis of the amide bond within MIF (melanocyte stimulating 
hormone release inhibiting factor), while retaining biological activity, the amide bond 
was replaced with the alkene functionality; (ii) in hopes of creating a double bond mimic 
of the D-Ala-D-Ala dipeptide, a unit used in bacterial cell wall synthesis (Figure 1.6). 
The preparation of the di- and tri-peptides incorporating proline and alanine analogues 
used a similar synthetic approach to Kelly consisting of hydroboration-oxidation of 
conjugated enynes to form βγ-unsaturated acids which are selectively alkylated to furnish 
the backbone with a second functionality.11 
 
 
Figure 1.6: Synthetic targets generated using direct alkylation by Sammes, Miles, et al. 
Figure adapted from Reference 11.  
  
1.2.3 Conversion of an Amide to an Ester 
Another option for backbone modification is the replacement of an amide bond 
with an ester bond. Ester linkages within the peptide backbone were predicted to be an 
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advantageous modification due to the conservative nature of mutation. Potential 
downfalls could be the increased flexibility around the ester linkage, as well as the 
differing electronic properties and solvation. For these reasons, more concrete data about 
the hydrogen bond strengths were of great interest. Synthesis of FmocProOGly was 
achieved in a three-step process in low yield, however, sufficient enough to incorporate 
into the peptide  [(ProProGly)4ProProOGly(ProProGly)5] upon condensation of dipeptide 
segments.12  
To examine the effects of the amide to ester bond mutations, a very commonly 
known triple-helical protein, collagen, was used. Incorporation into the helix showed that 
the E-olefin replacement of the amide bond was in fact unfavorable, especially in 
comparison to an ester mutation as determined through circular dichroism and thermal 
melting experiments assessing helical stability and ellipticity. The ester has been shown 
to induce minimal structural perturbations. Hydrogen bond strengths were estimated to be 
approximately 2.0 kcal/mol. The alkene moiety, however, did not appear to be a 
sufficient substitute of the amide bond in this situation, and was a much less stable 
surrogate. Proposed rationale to this observation includes unfavorable ϕ and ψ torsion 
angles for triple helix formation, low dipole moment, decreased solvation, etc. It is clear 
that the native secondary structure determines the compatibility of the E-olefin within the 
protein. Accommodation of the isostere is generally greater for β-sheets and β-hairpins, 
as opposed to α-helices.12 
Though the stability of an ester bond within a peptide is less than that of the 
native backbone amide, more susceptible to proteolytic and hydrolytic cleavage, the 
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mutation could help the understanding of the mechanistic properties of peptides that 
could potentially serve as therapeutic agents.  
 
1.2.4 Conversion of an Amide to a Thioamide 
A third alternative is the incorporation of a thioamide into a peptide backbone 
(Figure 1.7). Conversion of the carbonyl of an amide bond to a thiocarbonyl has several 
effects on the stability of a peptide. Though it is a nearly isosteric replacement, 
characteristics of the amide bond are slightly altered. The sulfur atom has an increased 
steric bulk with respect to oxygen, radii differing approximately 45 pm (65 pm for O, 109 
pm for S). Sulfur is also slightly less electronegative than oxygen. Consequently, the 
hydrogen bonding properties are altered. The thiocarbonyl (sulfur atom) becomes a 
weaker hydrogen bond acceptor, while the hydrogen bonding properties of the amide 
proton become stronger. Figure 1.8 displays the steric differences between an amide and 
thioamide linkage.  
 
 
Figure 1.7: Conversion of amide bond to thioamide linkage. Arrows indicate the position 
of changes in the H-bonding donor (N-H) and acceptor (C=S).  
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The investigation of the stability of helical peptides containing a thioamide 
linkage has been carried out by Julia Miwa from Wellesley College. Several predictions 
were made prior to their study with respect to the effects of the sulfur atom in the 
hydrogen bonding network. Two possible scenarios proposed were (i) the hydrogen 
bonding network will be perturbed and α-helix formation will be prevented, or (ii) the 
helix will fold with a distortion at the thioamide region while excluding the sulfur from 
the hydrogen bonding network. Positioning at the C-terminal region of the helix should 
pose no disruption because the last four residues do not participate in H-bonding.13 
 
     
 
 
112.63 Surface Area (Å2) 121.69 
80.28 Volume (Å3) 88.96 
-0.605 Partial Charge (=O, S) -0.496 
0.320 Electrostatic Charge (-NH) 0.175 
 
Figure 1.8: Spartan images and analysis of the spatial orientation of an amide versus a 
thioamide bond.  
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Miwa tested these hypotheses with sedimentation equilibrium and CD 
experiments that showed that the peptides preferentially fold into parallel α-helical coiled 
structures nearly identical to their native structure. They were able to show a substantial 
compatibility of the mutation at different locations within the helix, as well as at the C-
terminus (Figure 1.9), proving that the relative stability between mutants and wild-type 
were comparable.13  
 
 
Figure 1.9: Sequence and helical wheel diagram of thioamide linkages incorporated into 
two different locations: Leu-15 and Leu-28, replacing the carbonyl oxygen with sulfur.13 
 
Previous to this work, Miwa studied the effects of thioamide linkages within β-
sheet conformations, specifically β-hairpins. The mutation was made within the type II’ 
β-turn region of the hairpin, allowing the N-thioacyl amino acid to adopt the extended 
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conformation required for an antiparallel β-sheet, positioning the sulfur toward the 
exterior of the hairpin. The amide proton, however, still serves as a H-bond donor. Using 
two-dimensional NMR (specifically ROESY) to analyze long-range NOEs and COSY 
and TOCSY for resonance assignments, as well as circular dichroism spectroscopy to 
analyze the conformation of the peptide, they proved the persistence of a very similar 
hairpin conformation to that of the oxo peptide, however, no information on the relative 
stability is reported.14 
Peptides used by Miwa were synthesized using Fmoc solid-phase synthesis, while 
performing thioacylation within the peptide using Fmoc-Gly-thioxo-6-
nitrobenzotriazolide.13 Similarly, Rapoport and group from the Lawrence Berkeley 
National Laboratory at the University of California have developed a method using a 
nitrobenzotriazole as a thioacylating agent. The three-step reaction sequence shown 
below in Scheme 1.2 involves the coupling of 4-nitro-1,2-phenylenediamine with a N-
Boc amino acid, followed by direct thionation using phosphorus pentasulfide in basic 
conditions. The synthesis is completed with an intramolecular diazonium cyclization 
using nitrous acid generated in situ. To test their thioacylating efficiency, the 
benzotriazole was coupled with α-methylbenzylamine, which produced the desired 
coupling product in high yield and enantiomeric purity.15 
 
 
Scheme 1.2: Synthesis of benzotriazoles designed by Rapoport. Figure adapted from 
Reference 15.  
  
20
 
 Studies using thioamide bond mutations are advantageous to the field of peptide-
based drug design because of their structural similarity to the native backbone amide. 
Mutants can not only help to probe mechanisms, but can more importantly help enhance 
the enzymatic stability of peptides.  
 
1.2.5 Additional Heterogeneous Backbones  
As research in this field became increasingly intriguing and important, many 
others joined in pursuit of peptide drug design. Over the last decade, Samuel Gellman has 
made enormous progress in the field of heterogeneous backbones within a variety of 
foldamers. Foldamers are non-natural oligomers that display discrete folding 
propensities, and thus have the potential to exhibit biopolymer-like conformational 
tendencies, proving a sufficient mimic of various protein systems. Gellman proposed that 
foldamers were an ideal platform to study structure-activity relationships among peptides 
and their analogues. Backbones containing both α- and β-amino acids have been a main 
focus of study (see Figure 1.10). To expand the backbone artillery, several forms of the 
β-amino acids are used, including protein-like side chains and even cyclic structures for 
rigidity. Since new antimicrobial agents are in great need, the ability to synthesize 
peptides to directly mimic naturally occurring host-defense peptides is desirable and 
could lead to a variety of potential biomedical applications. Furthermore, success in 
Gellman’s project could have a profound impact on modern chemistry and medicine.16 
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Figure 1.10: Various β-residues used in heterogeneous backbone. Figure adapted from 
Reference 16.   
  
1.3 Experimental Goals  
 
 Chemical mutation will be used to study the structure formation and membrane-
lytic mechanism of a variety of peptides in order to expand the scope of peptide-based 
drug design and improve upon the drug-likeness of antimicrobial peptides. Key research 
goals include (i) improving the protease resistance of peptide therapeutics in order to 
alleviate delivery via injection and (ii) improving the potency of peptide therapeutics by 
tuning the conformation to its functional form and disfavoring the nonfunctional 
conformation. Thioamide linkages will be installed into a variety of peptides, and several 
analytical tools will be used to assess the outcome of the mutation on the structure and 
function of the peptides.  
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1.3.1 Structural Effects of Thioamides in Soluble Peptides 
 By incorporating thioamide linkages into a variety of soluble peptides, we hope to 
quantify their effects in protein conformation and stabilization. Examples of the systems 
that will be studied include the well known peptides gb1 and Trpzip 4. Circular dichroism 
and 1H-NMR are two main tools that will be used to measure the stabilities of the mutant 
peptides.  
 
1.3.2 Thioamides in Gramicidin A: Effects on Channel Formation 
Gramicidin A is a well-studied peptide with significant bactericidal activity as a 
result of its permeability into bacterial cell membranes. This peptide is thus optimal for 
studying the structure and function of membrane proteins. Gramicidin A is a 15-residue 
hydrophobic peptide composed of alternating sequence of D- and L-amino acids that 
exists in two major conformations: a β-helical ion channel and an intertwined double-
helical structure, the non-channel form.17 The interconversion of the two conformations is 
an interesting area of study. Thioamide linkages will be introduced into Gramicidin A in 
order to test the conformational preference of the peptide. The effects of the mutation in 
antimicrobial peptide design will be analyzed.  
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CHAPTER 2 
Results and Discussion 
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2.1 Synthesis of Thiolating Amino Acids 
 
Thiopeptides were prepared using organic synthetic schemes similar to that 
employed by Rapoport in his studies of thioacylating reagents.15 First, the mixed carbonic 
anhydride methodology for peptide synthesis was employed in order to couple the N-
Fmoc amino acid with 4-nitro-1,2-phenylenediamine. Next, the conversion of the 
carbonyl to a thiocarbonyl was accomplished by direct thionation using phosphorus 
pentasulfide and sodium carbonate. After purification of the thioamide, an intramolecular 
diazonium cyclization using nitrous acid generated in situ with sodium nitrite and acetic 
acid yielded the final product. Amino acid derivatives synthesized were tryptophan, 
phenylalanine, glycine, and D-leucine in varying yields (42-69%). This method, shown in 
Scheme 2.1, proved versatile for a range of amino acids, as well as being a short and 
efficient route. The  
 
 
Scheme 2.1:  Synthesis of Benzotriazole Thioacylating Agents used Directly in SPPS. 
 
incorporation of the thioamide into the molecule was verified after thionation based on a 
characteristic resonance between 200-213 ppm in the 13C-NMR spectrum (Figure 2.1). 
The puritiy of each amino acid derivative was also confirmed using HR-MS.  
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Figure 2.1: Sample 13C-NMR spectra of 2b proving the incorporation of the sulfur 
carbonyl based on the characteristic resonance at 207.3 ppm.  
 
2.2 Thioamides in Soluble β-Hairpins 
 
In order to investigate the effects of a thioamide linkage within a protein, an ideal 
model system had to be chosen. The simplest structural protein motif is the β-hairpin, 
comprised of two beta strands adjacent in primary structure oriented in an antiparallel 
arrangement linked by a short loop of two to five amino acid residues. These hairpins can 
exist on their own or can contribute to a larger protein structure such as a beta sheet or 
globular proteins. Given that hairpins are typically short, ranging from 10-20 amino 
acids, the complexity of analyzing the system is minimized in comparison to larger 
proteins. It was thus crucial to find a suitable β-hairpin to introduce thioamide linkages at 
various positions in order to understand their contributions to the overall peptide 
structure. 
  
26
 
One system of study was gb1, a β-hairpin peptide taken from the B1 IgG-binding 
domain of protein G. Gb1 has been shown to exhibit partial hairpin character, 
approximately 40% determined by NMR.18  
 
PEPTIDE  SEQUENCE    DETAILS                        _                 
gb1, 41-56  GEWTYDDATKTFTVTE  Type I turn 
Trpzip 4  GEWTWDDATKTWTWTE  gb1: Y45W, F52W, V54W 
 
Table 2.1: Sequences of Trpzip 4 and gb1, allowing for comparable peptide systems.  
 
 
 
 It is hypothesized that the installation of a thioamide linkage would enhance the 
stability within the peptide, making gb1 a suitable system to detect the effects of the 
mutation. In order to validate this hypothesis, both wild-type gb1 and thioamide mutant 
F12*Fgb1 were synthesized using solid-phase peptide synthesis (SPPS). The Phe-
benzotriazole was directly incorporated into SPPS. After peptides were synthesized and 
purified via RP-HPLC, concentrations were calibrated using UV/Vis spectroscopy, and 
samples were tested using CD to assess the secondary structures of the peptides, as well 
as their stabilities. Wavelength scans for the peptides were inconclusive, and thermal 
denaturation was unsuccessful on account of the peptides’ low stability. No conclusion 
could be made about the stability of the thioamide within the gb1(41-56) hairpin. 
We then attempted to circumvent this problem with a more stable version of gb1: 
Trpzip 4. The sequence of Trpzip 4 is a gb1 variant with three mutations (Table 2.1). 
Tryptophan zippers are a structural motif that provide an unusual amount of stability to 
the β-hairpin conformation within short peptides due to the cross-strand pairs of indole-
rings.19 Trpzip 4 is an example of such a peptide. Incorporation of a thioamide into the 
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peptide backbone was accomplished by introduction of a thioacylating reagent (Trp-
benzotriazole) as the fifth residue (W5*W-Trpzip 4) during solid phase peptide synthesis. 
After purification, the structure and stability of the mutant peptide was analyzed.  
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Figure 2.2: CD spectra of wild-type Trpzip 4 versus W5*W-Trpzip 4 (50 μM, 25°C). 
 
First, the secondary structure of the peptide was obtained using circular dichroism 
(Figure 2.2). Both a maximum at approximately 228 nm (Trp-aromatic interactions) and a 
minimum at approximately 215 (indicating its beta-character) were observed. The 
thioamide mutant, W5*W-Trpzip 4, adopted an identical conformation to that of the 
wild-type peptide.19  
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Figure 2.3: Thermal denaturation of W5*W-Trpzip 4 monitored by CD. Melting data 
was acquired with 50 μM peptide samples in 20 mM sodium phosphate buffer, pH 7.0. 
 
Next, thermodynamic properties of W5*W-Trpzip 4 were analyzed using thermal 
denaturation data collected by CD spectroscopy (Figure 2.3). Melting temperatures and 
various thermodynamic parameters were extracted from the data (Table 2.2) and 
compared to data collected by Cochran for wild-type Trpzip 4.19 Experimental conditions 
varied slightly (20 μM samples in potassium phosphate buffers, pH 7.0), however, data 
remains comparable.  
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 Trpzip 4 W5*W-Trpzip 4 
Tm, K 343 339 
ΔHm, kcal⋅mol-1 21.9 19.7 
ΔSm, cal⋅mol-1⋅K-1 63.7 58.2 
ΔCp, cal⋅mol-1⋅K-1 380 409 
ΔGf, kcal⋅mol-1 -1.25 -1.33 
 
Table 2.2: Thermal unfolding analysis of Trpzip 4 and W5*W-Trpzip 4.  
 
It is evident that data obtained from the thermal melts show the mutant and wild-
type peptides to be very similar in their melting temperatures, entropic and enthalpic 
values, and the heat capacity. Furthermore, both structural and thermodynamic data prove 
that the thioamide linkage was well-accommodated within the tryptophan zipper and the 
peptide exhibited comparable stability to the native conformation of the wild-type. 
Another peptide system and a new set of analytical tools were used for the next 
study. One appealing technique to quantify peptide folding has been used by Marcey L. 
Waters in her studies of various aromatic interactions within β-hairpins.20, 21 Since the 
extent of folding in a β-hairpin directly correlates to the separation of the glycine Hα 
resonances, 1H-NMR spectroscopy can be used for analysis. A simple calculation can 
then determine the population of folded peptide. Shown below is the equation used by 
Water’s, where the fraction folded is equal to the difference in the chemical shift of the 
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observed peptide versus the random coil control divided by the difference in the chemical 
shift of the fully folded and random coil control.20 This formula is followed by the 
simplified equation, mathematically derived from Water’s data by Kristofer Comeforo, 
directly used in this study, where x = Δδ Gly-Hα. Thus, the fraction of peptide folded can 
be found directly using 1H-NMR spectra. 
 
⇒ 
 
Equation 2.1:  Fraction of peptide folded 
 
In order to utilize this strategy employed by Waters, peptide design is quite 
imperative. The peptide sequence used by Waters (Figure 2.4),20-22 modified from a β-
hairpin originally developed by Gellman and co-workers,23 was adopted as it appeared to 
be an adequate system for this study (Ac-RFVOVNGKEIFQ-NH2). Several factors must 
be considered when deciding upon a peptide system, such as solubility, preferred 
conformation, etc. The chosen peptide has a net charge of +2 which is not only optimal 
for solubility enhancement, but also for aggregation prevention. Also, the turn region 
contains an Asn-Gly moiety known to readily induce a type I’ turn for β-hairpin 
formation.20   
⎥⎥
⎥
⎦
⎤
⎢⎢
⎢
⎣
⎡
−
−=
0100
0
δδ
δδobs
fF ⎥⎦
⎤⎢⎣
⎡ +
575.0
01000598.0x
  
31
 
 
Figure 2.4: Peptide sequence used to probe the influence of the incorporation of a 
thioamide linkage within the backbone of a β-hairpin.21 
 
Phenylalanine seemed to be an appropriate target for the incorporation of the 
thioamide linkage because of its relative location within the peptide. Because the 
behavior of the glycine residue is the probe for the study, the turn region was avoided, 
and thus the Phe residue (position 2) within the C-terminal beta strand was chosen. The 
peptides were synthesized using Fmoc-strategies with solid phase peptide synthesis 
(SPPS) and purified using reverse-phase HPLC. Masses were confirmed using LC-MS.  
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β-Hairpin Sequence % Folded ΔGf  (kcal⋅mol-1) 
Ac-RFVOVNGKEIFQ-NH2 39 0.25 
Ac-R*FVOVNGKEIFQ-NH2 55 -0.11 
 
Table 2.3:  β-hairpin Stabilities Determined from Glycine Chemical Shifts at 295 K.  
 
The peptides were then subjected to 1H-NMR experiments in D2O/AcOD buffer 
(pH 5.0) to compare the structural integrity of the wild-type peptide versus its thioamide 
mutant F2*F-MW-β-hairpin. The experimental data collected at 22°C is shown in Table 
2.3. Note that since these peptides interconvert between folded and unfolded 
conformations rapidly on the NMR time scale, the data collected in the form of chemical 
shifts is actually the average of the folded and unfolded states.  
Because of the simple mutation of an oxygen to a sulfur carbonyl, the native 
behavior of the peptide was altered. Sulfur has a larger atomic radius than oxygen, thus 
one could predict that its increased steric bulk could introduce a folding barrier within a 
β-hairpin. Accommodating the increased size could compromise its foldedness, however, 
in this β-hairpin, it was in fact enhanced. Data obtained at 22°C clearly indicates that the 
thioamide linkage provided additional stability to the peptide, increasing β-sheet 
propensity. The benefit of the strengthened H-bond donor on account of the electron-
withdrawing strength of the carbonyl sulfur was clearly displayed.  
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2.3 Thioamides in Antimicrobial Peptides: Gramicidin A 
 
Since it was proven that a thioamide within Waters’ β-hairpin boosted the 
peptide’s stability, it would be beneficial to investigate its role within another system. 
Gramicidin A (gA), a well-studied peptide, is an optimal system for studying the 
structure and function of membrane proteins. Gramicidin A is a 15-residue hydrophobic 
peptide composed of alternating sequence of D- and L-amino acids: Formyl-L-Val1-Gly2-
L-Ala3-D-Leu4-L-Ala5-D-Val6-L-Val7-D-Val8-L-Trp9-D-Leu10-L-Trp11-D-Leu12-L-Trp13-D-
Leu14-L-Trp15-ethanolamine. There are two well-known native conformations of gA 
(Figure 2.5). The first conformation is where two right-handed beta-helical monomers 
orient themselves N-terminus to N-terminus forming a monovalent cation selective 
channel in lipid bilayers (right).17 The second conformation is an intertwined double-
helical structure, also called the double-stranded dimer (left). It is believed to be a 
misfolded form of gA with no apparent channel activity. The interconversion of the two 
conformations is an interesting area of study, and furthermore, gA serves as a perfect 
system to analyze the factors most influential on its conformation as probed by SEC-
HPLC, CD, UV/Vis, fluorescence, TLC, etc.17, 24-28 
 
Figure 2.5: A schematic drawing of the gramicidin backbone illustrating some of the 
salient features for the conversion of double-stranded dimer to a beta-helical channel.17 
  
34
 
Conformation of gA has been proven to be highly solvent-dependent, but other 
features of the peptide can be easily probed in order to investigate its behavior in greater 
detail. This provides a perfect foundation for the incorporation of the thiopeptides. By 
perturbing the hydrogen-bonding network, the conformation of the peptide could be 
altered, either favorable or unfavorably.  
Again, it was essential to select a position within the peptide where the amide 
proton is a participant in the hydrogen bonding network, but the thioamide is not, 
therefore, the steric bulk of the sulfur atom does not provide an additional factor to 
perturb the system. Because the amide proton becomes a stronger hydrogen bond donor, 
the intermolecular forces within the peptide are changed which may or may not be 
accompanied by a conformation change.  
Gramicidin A contains four tryptophan residues (9, 11, 13, 15). Tryptophan is an 
abundant amino acid within membrane proteins, including many other ion channels. This 
amino acid tends to cluster near the membrane-water interfacial region of transmembrane 
domains of the proteins. Its hydrogen bonding ability, permanent dipole moment, and 
large aromatic ring play an important role in both its structure and function, mainly due to 
its high accessibility for π-π and cation-π interactions.29 It was part of this experimental 
design to synthesize both wild-type (WTgA) and a di-phenlyalanine mutant (W9,11FgA), 
which functions as a control to validate the experimental methods. It is known that the 
wild-type exists predominantly in the monomeric form, whereas the double mutant exists 
in some ratio of the two forms, channel and non-channel.  
Then, the thiopeptides were introduced into gA containing the double 
phenylalanine mutation. Positions 10 and 12, both D-Leucine residues, were targeted, 
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providing two thioamide (T) mutants: W9,11FgAT10 and W9,11FgAT12. Again, at each 
of these positions within the channel conformation, the carbonyl is oriented outward to 
accommodate the sulfur atom’s steric bulk, and the amide proton is donated within the H-
bonding network. This, however, is disfavored in the non-channel conformation because 
both the carbonyl and amide proton are engaged in hydrogen bonds within the double-
stranded dimer (Figure 2.6). The size of the sulfur atom, therefore, would perturb the H-
bonding network.  
Gramicidin A and mutants were synthesized guided by published procedures27 
using Fmoc chemistry by SPPS on a preloaded Trp-Wang resin. N-Formyl-valine was 
synthesized and purified via organic synthesis and recrystallization. The thiopeptide was 
introduced into the peptide at the selected position in DMF. Coupling time for 
benzotriazoles was extended and monitored using UV/Vis spectroscopy.30 Once the 
coupling of benzotriazoles exceeded 90%, the peptides were capped by acetylation (10% 
acetic anhydride in DMF, 1 hour at room temperature), after which peptide synthesis was 
allowed to complete (natural amino acid coupling >99%). The peptide was cleaved from 
the resin using distilled ethanolamine, providing the functionalized C-terminus. 
Precipitation in methanol with water, followed by centrifugation, and finally 
lyophilization, afforded the peptide as a white powder. Purity and chemical integrity were 
confirmed with LC-MS.  
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Figure 2.6: Mutated residues of gA dimers (D-Leu10,12) shown in yellow. Channel 
conformation of gA (left) with the second monomeric subunit shown in cyan with side 
chains. Note: carbonyl is oriented away from the channel. Non-channel conformation 
(right) with the second gA strand shown in cyan. Note, carbonyl engages in hydrogen 
bonding.  
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To understand the behavior of the peptides, several methods were used, including 
size exclusion high performance liquid chromatography (SEC-HPLC) and circular 
dichroism. As previously mentioned, the molecular structure and dynamics of gA are 
strongly environment-sensitive, so all tests were carried out in both polar (methanol) and 
nonpolar (tetrahydrofuran) solvents.  
It would be beneficial to examine the conformation of the peptides in a 
membrane, but preliminary tests were necessary to confirm their behavior in solution. 
Previous reports of SEC-HPLC have been used with an isocratic THF eluent to determine 
the conformation of gA in various solvents.26-29 Each of the four peptides of interest were 
dissolved in two different solvents (40 μM) and immediately injected (5 μL) onto the 
size-exclusion column at room temperature. Elution times and peak integrations (Table 
2.4) were monitored as a clear reflection of the preferred conformation under each 
condition. All experiments were repeated for accuracy.  
   A      B 
 
 
 
 
 
 
Figure 2.7: Sample traces from SEC-HPLC. (A) WTgA in MeOH; monomer elution at 
8.5 min, followed by solvent peaks. (B) WTgA in THF; monomer elution at 8.5 min 
(52%), dimer elution at 8.0 min (48%).  
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Sample traces of SEC-HPLC data are shown in Figure 2.7. Data indicates the 
thioamide mutants gAT10 and gAT12 clearly favor a monomeric structure based on the 
high percentage of the later elution product (approximately 8.5 minutes) regardless of 
solvent conditions, whereas WTgA and W9,11FgA show significant percentages of dimer 
product in THF. It is unknown, however, as to what the actual structure of these 
monomers and dimers are. Further tests must be carried out to fully characterize the 
secondary structure of these peptides, specifically when inserted into a membrane.  
 
PEPTIDE SOLVENT
MONOMER DIMER 
Elution Time % Elution Time % 
WTgA 
THF 8.50 52 8.00 48 
MeOH 8.50 100 -- -- 
W9,11FgA 
THF 8.55 29 8.11 71 
MeOH 8.55 100 -- -- 
W9,11FgAT10 
THF 8.89 94 8.05 6 
MeOH 8.89 100 -- -- 
W9,11FgAT12 
THF 8.50 91 8.05 9 
MeOH 8.50 100 -- -- 
 
Table 2.4: SEC-HPLC data collected from 5 μL injections of 40 μM sample eluted with 
isocratic THF. Monomer/dimer ratios estimated with peak integration.  
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Circular dichroism was also used as a guide to determine the secondary structure 
of the peptides. Experiments were run at room temperature in methanol, tetrahydrofuran, 
and trifluoroethanol (40 μM). Scans were taken after initial dissolvation and 1 hour later 
to see if there was any conformational change over a short period of time. Traces, 
however, were somewhat inconclusive due to variances in experimental data in 
comparison to literature data for the WTgA. Another method was thus attempted to 
understand the structure of gA and its mutants. 1H-NMR data was collected using 
samples of the peptides in different solvents (CD3OH and CD3OD) in hopes to monitor 
the Trp amide proton to learn more about its involvement in the H-bonding network, 
however, exchange was too fast to make any conclusions.  
 
 
Figure 2.8: Chemical structure of 8-hydroxypyrene-1,3,6-trifulfonate (HPTS). 
 
The final attempt to understand the behavior of these peptides was a functional 
assay, performing leakage experiments using fluorescence. Liposomes (500 μM) were 
prepared from DOPC, hydrated with sodium phosphate buffer containing HPTS (8-
hydroxypyrene-1,3,6-trisulfonate; Figure 2.8), a hydrophilic pH sensitive dye, and 
purified using gel filtration (removing external HPTS). They were then exposed to an 
external environment containing aqueous cesium chloride (10 μM). Sodium hydroxide 
  
40
 
(2.5 nM) was titrated into the extravesicular solution, creating a pH gradient of 
approximately 0.5 pH units across the membrane (pH 7.0 inside, pH 7.5 outside). Once a 
plateau in fluorescence intensity was achieved, peptide (1.25 μM) was added. Upon 
titration of the peptide to the solution, internal protons were released from the liposomes, 
compensated by Cs+. The internal pH of the liposomes increased because of proton 
efflux, thus causing deprotonation of the HPTS. See Figures 2.9-2.10.   
 
 
Figure 2.9: Schematic representation of transport experiments. A pH gradient results 
from addition of extravesicular NaOH solution. The charge caused by H+ efflux is 
compensated by cation influx, as mediated by the exogenous ligand, gramicidin A. The 
increase in intravesicular pH, monitored by the entrapped pH-sensitive dye, HPTS, 
reflects the electrolyte exchange rate.31 
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Figure 2.10: Sample fluorescence trace. Note, NaOH addition at 100 seconds, peptide 
addition shortly after 200 seconds, and finally Triton X-100 addition around 500 seconds.  
 
Transport properties of gramicidin A and mutants were quantified using this 
technique. Several experiments were performed in order to optimize the conditions for 
the experiment, as well as collect sufficient data in order to most accurately quantify the 
results. Fluorescence traces were analyzed quantitatively by probing the kinetics of each 
peptide. Exponential fits using Origin8 were performed on each curve to determine half-
life values. See Figure 2.11.  
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A      B 
 
 
 
 
 
C 
Figure 2.11 A-C: Trials 1-3 of leakage assay monitored by fluorescence. Black trace- 
THF (blank); Red trace- WTgA; Blue trace- W9,11FgA; Teal trace- W9,11FgAT10; Pink 
trace- W9,11FgAT12.  
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 TRIAL 1 TRIAL 2 TRIAL 3 AVERAGE
PEPTIDE t1/2 Error t1/2 Error t1/2 Error t1/2 Error 
WTgA 12.4 0.17 12.1 0.096 12.7 0.15 12.4 0.14 
W9,11FgA 40.6 0.26 35.1 0.31 -- -- 37.7 0.29 
W9,11FgAT10 33.0 0.23 8.17 0.20 17.6 0.15 19.6 0.19 
W9,11FgAT12 10.0 0.43 5.82 0.15 9.68 0.13 8.50 0.24 
 
Table 2.5: Kinetic data from leakage assays monitored by fluorescence.  
 
 From the data shown in Table 2.5, we can see that W9,11FgA insertion into the 
membrane is much slower than WTgA. The thioamide mutants, however, show enhanced 
channel formation, as indicated by half-lives less than that of the W9,11FgA. 
W9,11FgAT12, the thioamide mutation at the twelfth position, seems to embed into the 
liposome at a faster rate than W9,11FgAT10, producing half-lives less than the 
W9,11FgA and even WTgA. Data clearly show the favorable incorporation of the 
thioamide linkage into gramicidin A based on its efficiency to cause leakage across a 
membrane.  
Kinetic experiments were run with a final peptide concentration of 1.25 μM, 
however, to ensure that lipsomes weren’t saturated with peptide, detergent was added. 
Upon Triton X-100 addition, an increase in fluorescence intensity was detected, which 
was initially interpreted as the point of complete lysis. After analyzing the data from 
wild-type and mutants, it was suspected that the liposomes may in fact be saturated. Each 
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peptide resulted in the same maximum intensity (Figure 2.12). Concentration dependence 
experiments were then carried out, and it became evident that peptides were indeed 
saturating the liposomes.  
 
 
 
 
 
 
 
 
Figure 2.12: Saturation of liposomes with various concentrations of wild-type gramicidin 
A. Red trace- 250 nM; Blue trace- 25 nM; Teal trace- 2.5 nM; Black trace- THF [blank].  
 
 t1/2  (s) Stnd Error 
THF (blank) 190. 8.6 
0.25 μM 56.6 0.64 
1.25 μM 12.2 0.096 
2.5 μM 7.32 0.11 
 
Table 2.6: Half lives of WTgA of varying concentrations calculated from leakage 
experiments as monitored by fluorescence.  
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Later experiments with lower concentrations were performed, showing that a 
more optimal peptide concentration would be on the nanomolar scale (Figure 2.13), 
where maximal leakage is not achieved until Triton X-100 is added.  
 
 
 
 
 
 
 
 
Figure 2.13: Concentration dependence of leakage using wild-type gramicidin A. Red 
trace- 250 nM; Blue trace- 25 nM; Teal trace- 2.5 nM; Black trace- THF [blank].  
 
 t1/2  (s) Stnd Error 
THF (blank) 462 30. 
250 nM 44.2 0.82 
25 nM 145 2.6 
2.5 nM 234 5.4 
 
Table 2.7: Kinetic analysis of concentration dependence of leakage using WTgA. Half-
life values reported as calculated from Exponential Fit using Origin8. 
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 Why, then, did the fluorescence intensity increase after addition of detergent? In 
order to investigate this pattern, phosphate buffer was prepared to best mimic the 
environment in the previous gA experiments directly before Triton X-100 titration (30 
nM HPTS, pH 7.5) and placed in the fluorescence cuvette. The fluorescence intensity was 
monitored for 100 seconds upon which Triton X-100 was added. Based on the relative 
change in intensity, it was verified that there is some arbitrary non-specific effect of the 
detergent on the liposomes, proving saturation was indeed reached with 1.25 μM gA. A 
mathematical estimation validates this conclusion. If we assume that each liposome 
contains roughly 50,000 lipid molecules, then the final liposome concentration used in 
these experiments was approximately 10 nM. Technically only one gA channel is 
necessary for leakage, and thus at micromolar concentrations of gA, peptide levels are 
well beyond saturation.  
Future experiments may be necessary to better analyze the efficiency of these 
channel-forming peptides. Not only could a more accurate analysis of kinetics be 
achieved, but also, it is possible that the thermodynamic analysis would be made 
accessible by interpreting maximum intensity values. Leakage assays using gA of less 
than 25 nM would be ideal. Also, the concentration dependence of leakage using each 
mutant would also be valuable data to obtain.  
Once these experiments are completed, it would be interesting to evaluate the 
proteolytic resistance of these mutant peptides, as well as their antibiotic efficiency in 
bacterial cells. If we could prove that the thioamide version of gramicidin A improves the 
enzymatic stability of the peptide, the applications of the mutation will expand 
dramatically.  
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CHAPTER 3 
Conclusion 
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Thioamide linkages were installed in a variety of soluble peptides, replacing the 
backbone amide linkage, in order to quantify the effects on the peptides’ conformation 
and stability. Through thermal melting experiments, the thioamide mutant W5*W-Trpzip 
4 showed comparable stability to its wild-type, Trpzip 4, a well-known tryptophan zipper. 
Using 1H-NMR, it was shown that the thioamide mutant F2*F-MW-β-hairpin was more 
stable than its wild-type based on the population of folded peptide and the free energy of 
folding.  
Secondly, the efficiency of the channel-forming antimicrobial peptide,  
gramicidin A, was improved by the respective backbone mutations, W9,11FgAT10 and 
W9,11FgAT12, as demonstrated by SEC-HPLC and fluorescence experiments. This 
could be a potential synthetic route to consider when developing AMP-like drug design.  
In conclusion, the thioamide mutation was shown to be well-accommodated 
within peptides with different secondary structures, and thus proved to be a useful and 
versatile modification. Future studies including similar backbone engineering could be a 
promising field and will hopefully make significant contributions to the field of peptide 
drug design.  
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General Methods: Synthesis of Thioacylating Reagents 
All 1H-NMR and 13C-NMR data were collected on a Varian Gemini/2000 400 MHz 
NMR Spectrometer. High resolution mass spectrometry was performed using electron 
spray ionization methods. 
 
α-N-Fmoc-L-tryptophan 2-amino-5-nitroanilide (1a) 
N-methylmorpholine (1.670 mL, 12.19 mmol) was added slowly to a solution of N-
Fmoc-L-Trp(Boc)-OH (4.000 g, 7.596 mmol) in dry THF (76 mL) at -20°C and stirred 
under nitrogen protection, followed by the dropwise addition of isobutyl chloroformate 
(0.990 mL, 7.596 mmol). The reaction was allowed to stir for 20 minutes after which 4-
nitro-1,2-phenylenediamine (1.163 g, 7.596 mmol) was added and stirred at -15°C for 2 
hours, then room temperature overnight. The reaction mixture was filtered through celite 
and the filtrate was evaporated to dryness. The residue was dissolved in ethyl acetate and 
washed consecutively with saturated NH4Cl, brine, sodium phosphate buffer (0.5 M, pH 
7.0), and brine. The combined organic fractions were dried with Na2SO4, filtered, and the 
solvent was evaporated under vacuum. The crude material was purified by flash column 
chromatography on silica gel (DCM/EtOAc, gradient of 12:1, 10:1, 9:1) to give the 
desired product 1a as a yellow solid (68%). 1H-NMR (DMSO) δ 9.48 (s, 1H), 8.05 (d, 
2H), 7.87 (d, 1H), 7.89-7.86 (m, 3H), 7.78 (d, 1H), 7.68-7.64 (m, 3H), 7.42-7.23 (m, 6H), 
6.76 (d, 1H), 6.44 (s, 1H), 4.54 (q, 1H), 4.26-4.18 (m, 3H), 3.30-3.20 (m, 1H), 3.11-3.04 
(m, 1H), 1.58 (s, 9H). 13C-NMR δ 171.6, 156.7, 150.1, 149.6, 144.3, 141.3, 136.0, 135.3, 
130.8, 128.2, 127.6, 125.9, 125.0, 124.7, 123.9, 123.0, 122.7, 121.5, 120.7, 120.2, 117.1, 
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115.3, 114.2, 84.1, 66.5, 55.7, 47.3, 28.3, 27.6. HRMS calcd for C37H35N5O7Na [M+Na] 
684.2429, found 684.2434. 
 
α-N-Fmoc-L-tryptophan 2-amino-5-nitrothioanilide (2a) 
Dry THF (690 μL) was added to P4S10 (31.0 mg, 69.6 μmol) and sodium carbonate (7.37 
mg, 69.6 μmol) and stirred at room temperature under nitrogen protection for 1 hour, 
after which the reaction mixture was cooled to 0°C and 1a (25.6 mg, 36.6 μmol) was 
added and stirred for 30 minutes. The reaction was then warmed to room temperature and 
stirred for 2 hours. The solvent was removed under vacuum. The residue was then 
dissolved in EtOAc/Hexane (2:1) and washed twice with sodium phosphate buffer (0.5 
M, pH 7.0). The aqueous wash was back extracted twice with EtOAc/Hexane (2:1). The 
organics were combined, washed with brine, dried with Na2SO4, filtered and solvent was 
removed under vacuum. Crude material was purified by flash column chromatography on 
silica gel (DCM/EtOAc, 2:1) to give the desired product 2a as a yellow solid (79%). 1H-
NMR (DMSO) δ 11.41 (s, 1H), 8.20 (d, 1H), 8.07 (d, 1H), 7.97 (d, ½ H), 7.94 (d, ½ H), 
7.89 (d, 2H), 7.83 (d, 1H), 7.76 (s, 1H), 7.71-7.68 (m, 3H), 7.42-7.27 (m, 6H), 6.79 (d, 
1H), 6.35 (s, 2H), 4.78 (q, 1H), 4.32-4.17 (m, 3H), 3.24-3.16 (m, 1H), 1.62 (s, 9H). 13C-
NMR δ 207.4, 156.9, 151.1, 149.7, 144.3, 144.1, 141.3, 135.9, 135.2, 130.8, 128.2, 
127.6, 126.0, 125.9, 125.6, 125.3, 125.1, 125.0, 123.0, 122.8, 120.7, 120.3, 116.9, 115.3, 
114.5, 84.2, 66.6, 61.7, 47.2, 30.0, 28.4. HRMS calcd for C37H35N5O6SNa [M+Na] 
700.2200, found 700.2206.  
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1-(N-Fmoc-L-thionotryptophaninyl)-6-benzotriazole (3a) 
2a (25.0 mg, 36.9 μmol) was dissolved in a solution of acetic acid/5% water (276 μL) by 
gentle warming and stirring at 40°C. The reaction mixture was cooled to 0°C and sodium 
nitrite (3.82 mg, 55.33 μmol) was added in small portions over 5 minutes. After 30 
minutes, ice water (1.9 mL) was added. The precipitate was filtered off, washed with ice 
water, and dried in the lyophilizer overnight to give 3a (95%). Material was produced in 
sufficient purity to be directly incorporated into SPPS. 1H-NMR (CDCl3) δ 9.58 (s, 1H), 
8.46 (d, 1H), 8.31 (d, 1H), 8.05 (d, 1H), 7.76-7.75 (m, 2H), 7.60-7.18 (m, 10H), 6.65-6.63 
(m, 1H), 5.78 (d, 1H), 4.46-4.42 (m, 2H), 4.33-4.29 (m, 1H), 4.20-4.18 (m, 1H), 3.55 (d, 
½ H), 3.53 (d, ½ H), 3.29-3.23 (m, 1H), 1.65 (s, 9H). 13C-NMR δ 208.1, 155.7, 149.7, 
149.5, 149.1, 143.8, 141.4, 135.4, 131.9, 130.1, 127.9, 127.2, 125.1, 124.9, 123.0, 122.4, 
121.6, 120.1, 119.0, 115.5, 114.5, 112.7, 84.1, 67.3, 61.5, 47.3, 32.7. HRMS calcd for 
C37H32N6O6SNa [M+Na] 711.1996, found 711.2002.  
 
α-N-Fmoc-L-phenylalanine 2-amino-5-nitroanilide (1b) 
N-methylmorpholine (1.670 mL, 12.19 mmol) was added slowly to a solution of N-
Fmoc-L-Phe-OH (2.943 g, 7.596 mmol) in dry THF (76 mL) at -20°C and stirred under 
nitrogen protection, followed by the dropwise addition of isobutyl chloroformate (0.990 
mL, 7.596 mmol). The reaction was allowed to stir for 20 minutes after which 4-nitro-
1,2-phenylenediamine (1.163 g, 7.596 mmol) was added and stirred at -15°C for 2 hours, 
then room temperature overnight. The reaction was filtered through filter paper (slow) 
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and the precipitate was collected and dried under vacuum. The crude material 1b was 
used directly in the next step.  
 
α-N-Fmoc-L-phenylalanine 2-amino-5-nitrothioanilide (2b) 
Dry THF (76.5 mL) was added to P4S10 (3.30 g, 7.65 mmol) and sodium carbonate (781 
mg, 7.65 mmol) and stirred at room temperature under nitrogen protection for 1 hour, 
after which the reaction mixture was cooled to 0°C and 1b (2.14 g, 3.92 mmol) was 
added and stirred for 30 minutes. The reaction was then warmed to room temperature and 
stirred for 2 hours. The solvent was removed under vacuum. The residue was then 
dissolved in EtOAc and washed twice with sodium phosphate buffer (0.5 M, pH 7.0). The 
aqueous wash was back extracted twice with EtOAc. The organics were combined, 
washed with brine, dried with Na2SO4, filtered and solvent was removed under vacuum. 
Crude material was purified by flash column chromatography on silica gel (DCM/EtOAc, 
12:1) to give the desired product 2b as a yellow solid (54%). 1H-NMR (DMSO) δ 11.27 
(s, 1H), 8.14 (d, 1H), 7.95-7.92 (m, 1H), 7.90 (d, 2H), 7.72 (t, 2H), 7.58 (s, 1H), 7.44-
7.25 (m, 10H), 6.75 (d, 1H), 6.20 (s, 2H), 4.70 (q, 1H), 4.31-4.28 (m, 1H), 4.23-4.18 (m, 
2H), 3.17-3.06 (m, 2H). 13C-NMR δ 207.3, 170.9, 156.8, 151.1, 144.4, 144.2, 141.3, 
137.9, 135.9, 130.1, 128.7, 128.3, 127.7, 127.2, 126.0, 125.9, 125.5, 125.2 
,122.8,120.7,114.5. HRMS calcd for C30H26N4O4SNa [M+Na] 561.1567, found 
561.1572. 
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1-(N-Fmoc-L-thionophenylalaninyl)-6-benzotriazole (3b) 
2b (0.95 g, 1.67 mmol) was dissolved in a solution of acetic acid/5% water (13.2 mL) by 
gentle warming and stirring at 40°C. The reaction mixture was cooled to 0°C and sodium 
nitrite (182 mg, 2.65 mmol) was added in small portions over 5 minutes. After 30 
minutes, ice water (85 mL) was added. The precipitate was filtered off, washed with ice 
water, and dried in the lyophilizer overnight to give 3b (88%). Material was produced in 
sufficient purity to be directly incorporated into SPPS. 1H-NMR (CDCl3) δ 9.64 (s, 1H), 
8.47 (d, 1H), 8.32 (d, 1H), 7.77 (d, 2H), 7.55-7.53 (m, 1H), 7.41-7.39 (m, 1H), 7.34-7.18 
(m, 10H), 6.60-6.58 (m, 1H), 5.70 (d, 1H), 4.45-4.33 (m, 3H), 4.21-4.19 (m, 1H), 3.45 (d, 
½ H), 3.42 (d, ½ H), 3.16-3.10 (m, 1H). 13C-NMR δ 208.0, 155.6, 149.7, 149.1, 143.7, 
141.4, 135.2, 131.9, 129.5, 128.7, 127.9, 127.6, 127.2, 125.2, 122.4, 121.7, 120.2, 112.8, 
67.3, 62.5, 47.4, 43.0. HRMS calcd for C30H23N5O4SNa [M+Na] 572.1363, found 
572.1368.  
 
α-N-Fmoc-L-glycine 2-amino-5-nitroanilide (1c) 
Protocol identical to the synthesis of α-N-Fmoc-L-tryptophan 2-amino-5-nitroanilide 1a. 
Crude material 1c was used directly in next step.  
 
α-N-Fmoc-L-glycine 2-amino-5-nitrothioanilide (2c) 
Protocol identical to the synthesis of α-N-Fmoc-L-tryptophan 2-amino-5-nitrothioanilide 
2a. The crude material was purified by flash column chromatography on silica gel 
(DCM/EtOAc, 6:1) resulting in desired product 2c (61%). 1H-NMR (DMSO) δ 11.06 (s, 
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1H), 7.96 (d, 2H), 7.75 (d, 2H), 7.44-7.32 (m, 4H), 6.85 (d, 1H), 6.55 (s, 2H), 4.35 (d, 
2H), 4.03 (m, 1H), 3.39 (s, 1H), 3.35 (s, 2H). 13C-NMR δ 203.2, 157.1, 151.3, 144.4, 
141.3, 135.8, 128.2, 127.7, 125.9, 125.6, 125.5, 122.9, 120.7, 114.5, 66.5, 60.4, 52.1, 
47.3, 21.4, 14.8. HRMS calcd for C23H21N4O4S [M+1]  449.12780, found 449.12835 
 
1-(N-Fmoc-L-thionoglycinyl)-6-benzotriazole (3c) 
2c (302 mg, 0.69 mmol) was dissolved in a solution of acetic acid/5% water (5.2 mL) by 
gentle warming and stirring at 40°C. The addition of DMF (2 mL) and MeCN (2mL) 
along with vigorous stirring was required to completely dissolve the substrate. The 
reaction mixture was cooled to 0°C and sodium nitrite (71.6 mg, 1.00 mmol) was added 
in small portions over 5 minutes. After 30 minutes, ice water (1 mL) was added. The 
precipitate was filtered off, washed with ice water, and dried in the lyophilizer overnight 
to give 3c (95%). Material was produced in sufficient purity to be directly incorporated 
into SPPS. 1H-NMR (CDCl3) δ 9.65 (s, 1H), 8.46 (d, 1H), 8.33 (d, 1H), 7.79 (d, 2H), 7.66 
(d, 2H), 7.45-7.33 (m, 4H), 5.22 (d, 1H), 4.51 (d, 2H), 4.30-4.27 (m, 1H), 2.96 (s, 1H), 
2.89 (s, 1H). 13C-NMR δ 202.4, 156.5, 149.7, 148.9, 143.8, 141.4, 131.9, 127.9, 127.2, 
125.2, 122.4, 121.7, 120.2, 112.6, 107.9, 67.5, 53.1, 47.4, 20.8. HRMS calcd for 
C23H18N5O4S [M+1]  460.10740, found 460.10795. 
 
α-N-Fmoc-D-leucine 2-amino-5-nitroanilide (1d) 
Protocol identical to the synthesis of α-N-Fmoc-L-tryptophan 2-amino-5-nitroanilide 1a. 
Crude material 1d was used directly in the next step. 1H-NMR (DMSO) δ 9.42 (s, 1H), 
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8.16 (d, 1H), 7.91-7.86 (m, 4H), 7.75-7.71 (m, 3H), 7.43-7.40 (t, 2H), 7.34-7.31 (t, 2H), 
6.77 (d, 1H), 6.43 (s, 2H), 4.35-4.20 (m, 4H), 1.75-1.63 (m, 1H), 1.63-1.51 (m, 2H), 0.99-
0.86 (m, 6H). 
 
α-N-Fmoc-D-leucine 2-amino-5-nitrothioanilide (2d) 
Protocol identical to the synthesis of α-N-Fmoc-L-phenylalanine 2-amino-5-
nitrothioanilide 2b. The crude material was purified by flash column chromatography on 
silica gel (DCM/EtOAc, 15:1-9:1) resulting in desired product 2d (69%). 1H-NMR 
(DMSO) δ 11.38 (s, 1H), 7.97 (m, 2H), 7.88 (d, 2H), 7.75 (m, 2H), 7.44-7.31 (m, 4H), 
6.79 (d, 1H), 6.73 (s, 2H), 4.52-4.24 (m, 3H), 3.32 (s, 1H), 1.76-1.69 (m, 3H), 0.98 (d, 
3H), 0.94 (d, 3H). 13C-NMR δ 208.8, 157.1, 151.3, 144.5, 144.2, 141.3, 135.9, 128.3, 
127.7, 126.0, 125.9, 125.6, 125.3, 123.0, 120.7, 114.5, 66.5, 60.3, 47.3, 43.5, 25.0, 23.5, 
22.6, 21.4, 14.8. HRMS calcd for C27H29N4O4S [M+Na] 527.1729, found 527.1729.  
 
1-(N-Fmoc-D-thionoleucinyl)-6-benzotriazole (3d) 
Protocol identical to 1-(N-Fmoc-L-thionotryptophaninyl)-6-benzotriazole 3a. Product 3d 
was produced in sufficient purity (75%) and thus directly incorporated into SPPS. 1H-
NMR (CDCl3) δ 9.67 (s, 1H), 8.45 (d, 1H), 8.31 (d, 1H), 7.78 (d, 2H), 7.61 (d, 2H), 7.41-
7.32 (m, 4H), 6.31-6.29 (m, 1H), 5.62 (d, 2H), 4.55-4.51 (m, 1H), 4.42-4.37 (m, 1H), 
4.24-4.22 (m, 1H), 1.91-1.79 (m, 3H), 1.12 (d, 3H), 0.97 (d, 3H). 13C-NMR δ 210.7, 
156.0, 149.7, 149.1, 143.8, 141.5, 132.1, 127.9, 127.2, 125.2, 122.3, 121.6, 120.2, 113.0, 
67.1, 60.7, 47.5, 46.1, 25.9, 23.5, 21.5. HRMS calcd for C27H26N5O4S [M+1] 516.17000, 
found 516.17055. 
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General Methods: Peptide Synthesis and Analysis  
Amino acids were purchased from Advanced Chemtech (Louisville, KY) and resins were 
purchased from Novabiochem (San Diego, CT). Peptide synthesis was carried out on a 
Tribute Peptide Synthesizer (Protein Technologies, Tucson, AZ). Peptides were 
centrifuged using a Damon/IEC HN-SII Centrifuge, with the exception of Gramicidin A 
(and mutant) peptides which were centrifuged using a Beckman Coulter Avanti® J-E 
Centrifuge. 1H-NMR data for the peptides were taken on a Varian Unity INOVA 500 
MHz NMR Spectrometer using a Varian 5 mm Broadband or Varian 5 mm Indirect 
Detection Probe. Circular dichroism measurements were taken on an Aviv Circular 
Dichroism Spectrometer, Model 202SF (Aviv Biomedical, Inc., Lakewood, NJ) using a 2 
mm quartz cell. Peptide concentrations were determined by measuring absorptions at 280 
nm on a Lambda 25 (PerkinElmer, Waltham, MA) in a 10 mm quartz cell. Liposomes 
were prepared from DOPC provided by Avanti Polar Lipids (Alabaster, AL). All 
peptides, except for Gramicidin A (and mutants) were purified by high performance 
liquid chromatography on Waters Prep LC System using a Waters 2489 UV/Visible 
Detector with a Jupiter 10u C18 300A Column (Waters Corporation, Milford, MA). 
Molecular masses of Gramicidin A (and mutants) were measured using Waters 2695 
Separations Module with the Waters Dual λ Absorbance Detector on a Jupiter 5u C4 
300A Column (Waters Corporation, Milford, MA) with a Micromass LCT (UK). Size-
exclusion high performance liquid chromatography was performed using Waters e2695 
Separations Module with a Waters 2489 UV/Visible Detector and a Styragel® HR 3 
(THF) Column (Waters Corporation, Milford, MA). 
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Preloading Fmoc-Trp-OH onto Wang Resin: Wang Resin [100-200 mesh] (1.0 g, 0.65 
mmol) was allowed to swell in DMF for 30-60 minutes. Meanwhile, Fmoc-Trp-OH was 
dissolved in 10% DMF in DCM (30 mL) and cooled to 0°C after which DIC (0.51 mL, 
3.25 mmol) was added dropwise and stirred under nitrogen for twenty minutes. DCM 
was then removed from the Trp using a vacuum. The reside was then dissolved in 
minimal volume of DMF and transferred to the swollen resin along with DMAP (7.9 mg, 
0.065 mmol) and stirred. After one hour, the DMF was drained and the resin was 
rinded/swirled with DMF (6 X 5 mL) and finally dried with DCM. The loading capacity 
was tested using UV/Vis Spectroscopy according to a previously reported method30.  
 
Synthesis of Trpzip4, GB1, and MW-β-hairpin: Peptides were synthesized using 
automated solid phase peptide synthesis on a 0.1 mmole scale on Rink Resin SS [75-100 
mesh, 1% DVB, substitution: 0.7 mmole/gram]. Five molar equivalents of commercially 
available amino acids were used for the coupling reactions. The incorporation of 
unnatural amino acids was accomplished by using five equivalents of the Fmoc-protected 
amino acid with extended coupling times (2 hours). When applicable, peptides were 
acetylated using acetic anhydride (10% in DMF, 1 hour, 25°C). The resin was then 
washed with DMF and dried using DCM. Peptides were cleaved from the dried resin and 
deprotected with Reagent K (85% trifluoroacetic Acid, 5% phenol, 5% thioanisole, 2.5% 
water, 2.5% ethanedithiol, 1 hour, 25°C). The resin was then filtered off, and the peptide 
was precipitated from the filtrate using diethyl ether (25 mL, -78°C). The mixture was 
centrifuged (8,000 rpm, 15 minutes, 25°C) and the supernatant was discarded. This 
procedure was repeated 2 times, and finally the peptide was dried under a stream of 
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nitrogen followed by high vacuum. Crude product was purified by RP-HPLC 
(CH3CN/H2O) upon which purified peptides were subjected to spectroscopic and 
thermodynamic analysis 
 
Synthesis of Gramicidin A and mutants: Peptides were synthesized using Fmoc strategy 
via automated solid phase peptide synthesis on a 0.1 mmole scale on Fmoc-Trp-Wang 
resin. Five molar equivalents of commercially available amino acids were used for the 
coupling reactions. The incorporation of unnatural amino acids was accomplished by 
using five equivalents of the Fmoc-protected amino acid with extended coupling time (2 
hours). Coupling was monitored using UV/Vis spectroscopy. Incomplete coupling was 
resolved by capping with acetic anhydride (10% in DMF, 30 min, 25°C). Following 
capping, the resin was rinsed in DMF and returned to SPPS. N-Formyl valine, 
synthesized according to literature,27 was introduced under the standard coupling 
conditions on SPPS. When the synthesis was complete, the resin was dried under vacuum 
for several hours, after which the peptides were cleaved from the resin with distilled 
ethanolamine (10% in DMF, 3 mL, 4 hours, 55°C). Upon completion, the reaction 
mixture was cooled to room temperature and filtered. The resin was rinsed with 
methanol, followed by dichloromethane and condensed to the original volume of 
cleavage solution (approx. 3 mL). The peptide was precipitated with Millipore water 
(approx. 20 mL) and placed on ice for 30 minutes. The mixture was centrifuged (14,000 
rmp, 2 hours, 4°C). The supernatant was discarded, and the pellet of peptide was 
resuspended in a minimal volume of methanol, re-precipitated with water (approx. 10 
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mL), placed on ice for 30 minutes, centrifuged, and then dried overnight under high 
vacuum resulting in a white powder. Identity and purity was verified using LC-MS.  
 
Preparation of Liposomes: Liposomes were prepared using 1,2-dioleoyl-sn-glycero-3-
phosphocholine.  DOPC (final concentration 50 mM,) was dissolved in chloroform and 
thoroughly mixed. Chloroform was removed under vacuum and allowed to dry overnight. 
Lipids were then hydrated with buffer (10 mM NaPi, 100 mM NaCl, 10 uM HPTS, pH 
7.0). Full encapsulation and vesicle formation was ensured by performing 20 freeze-thaw 
cycles (-78°C, 80°C), followed by extrusion (25 times) using an extruder with a 100 nm 
filter (Avanti Polar Lipids) to ensure uniform size. LUVs were then purified via gel 
filtration using a UPC-900 system with a sephacryl S-500 column (General Electric, 
Piscataway, NJ), eluted with 10 mM NaPi, pH 7.0. Purity of the eluent was monitored by 
UV/Vis. The resulting purified liposome stock was 10 mM.  
 
Leakage Assay using Fluorescence: To a 1.0 cm quartz cuvette with stir bar was added 
sodium phosphate (10 mM, pH 7.0, 1.640 mL), liposomes prepared according to 
procedure described above (10 mM, 100 μL), and cesium chloride solution prepared in 
NaPi buffer (1M, 200 uL). The emission of HPTS (λemission = 510 nm) was monitored at 
λexcitation = 460 nm. After 100 seconds, NaOH (0.5 M, 10 μL) was titrated into the cuvette. 
After signal reached a plateau (approx 200 s), gA sample (50 μM in THF, 50 μL) and 
continued to stir. At 500 seconds, Triton X-100 (5% in NaPi, pH 7.5, 40 μL) was titrated 
into the cuvette. Data was collected for 600 seconds.  
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